CONMED CorporationCNMDNYSE
LOADING
|||
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +5.78% | +2.88% | +3.09% | +6.70% | +7.88% |
| Gross Profit Growth | +8.88% | +3.37% | +2.50% | -7.19% | +5.08% |
| EBITDA Growth | +3.40% | -35.51% | -13.29% | -63.57% | -21.32% |
| Operating Income Growth | +4.61% | -54.42% | -18.99% | -81.92% | -11.88% |
| Net Income Growth | +2.07% | -69.37% | -28.54% | -94.16% | -50.41% |
| EPS Growth | +0.93% | -70.31% | -28.87% | -94.19% | -50.46% |
| EPS Diluted Growth | +2.86% | -69.84% | -28.13% | -94.13% | -50.00% |
| Weighted Average Shares Growth | +0.30% | +0.63% | +0.44% | +0.32% | +0.38% |
| Weighted Average Shares Diluted Growth | -1.24% | -0.39% | -0.17% | -0.20% | -0.26% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -23.15% | +42.63% | -32.73% | +4.85% | +0.00% |
| Free Cash Flow Growth | -23.75% | +39.39% | -41.07% | +1.50% | +0.00% |
| Receivables Growth | -1.88% | -8.42% | -2.12% | -2.72% | +0.00% |
| Inventory Growth | +8.92% | +10.05% | +12.38% | +6.37% | +0.00% |
| Asset Growth | +0.27% | -0.50% | +1.87% | +0.29% | +0.00% |
| Book Value per Share Growth | +15.05% | +13.68% | +13.23% | +7.73% | +0.00% |
| Debt Growth | -6.99% | -9.96% | -8.70% | -9.25% | +0.00% |
| R&D Expense Growth | -6.07% | -4.76% | +0.28% | +2.53% | +13.08% |
| SG&A Expenses Growth | +12.47% | +20.66% | +12.48% | +40.72% | +11.00% |